Bonine Tablet, Chewable
Product Images NDC 65197-275

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bonine (NDC 65197-275). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wellspring Pharmaceutical Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

16 Ct Carton Label (Bonine 1)

BONINE 25 mg chewable tablets packaging label for the oral tablet containing meclizine hydrochloride, an antihistamine for motion sickness. The blue carton highlights prevention and treatment of nausea, dizziness, and vomiting. It includes product usage, active ingredient info, warnings, directions, and inactive ingredients. Manufactured by WellSpring Pharmaceutical Corporation. The package contains 12 chewable tablets with raspberry flavor.*

FDA Label Image

8 Count Carton (Bonine 2)

BONINE 25 mg chewable tablets packaging label featuring the brand name BONINE prominently with the active ingredient meclizine hydrochloride. The label highlights its use for motion sickness, preventing and treating nausea, dizziness, and vomiting with less drowsiness than dimenhydrinate. The package contains 72 raspberry-flavored chewable tablets. Labeler is WellSpring Pharmaceutical Corporation. The design includes instructions, drug facts, and a barcode on a blue background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.